Impact of Rapid Detection of MRSA

NCT02027389 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2018-02-13

No results posted yet for this study

Summary

The objective of this study is to evaluate the impact of the Alere\™ PBP2a test combined with pharmacist review of antimicrobial therapy, on clinical outcomes and cost in hospitalized patients with sterile site S. aureus infection.

Conditions

  • Staphylococcus Aureus Infections

Sponsors & Collaborators

Principal Investigators

  • Ritu Banerjee, MD, PhD · Mayo Clinic

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2016-07-31
Completion
2016-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02027389 on ClinicalTrials.gov